TP53 and colorectal cancer: In a colorectal cancer cell model with tumor suppressor TP53 depletion, several DPP-4is (including vildagliptin, alogliptin and linagliptin) suppressed erastin-induced ferroptosis-mediated cell death, thus pointing to a therapeutic potential beyond DM (52).